Puma Biotechnology (PBYI) Total Debt (QoQ) (2018 - 2026)

Puma Biotechnology (PBYI) Total Debt (QoQ) (2018 - 2026) Analysis & Trends

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr)
1 Oculis Holding AG 68,785.72 Bn 68,785.72 Bn -
2 Nanobiotix 1,895.57 Bn 1,895.51 Bn -
3 BeOne Medicines 471.35 Bn 466.56 Bn 1.35 Bn
4 NuCana 279.75 Bn 279.75 Bn -
5 Vertex Pharmaceuticals 120.24 Bn 113.00 Bn 2.59 Bn
6 Regeneron Pharmaceuticals 67.80 Bn 59.04 Bn 3.31 Bn
7 Belite Bio 62.51 Bn 62.51 Bn -
8 Argenx Se 57.38 Bn 57.38 Bn 1.41 Bn
9 Revolution Medicines 37.78 Bn 37.78 Bn -
10 Puma Biotechnology 407.27 Mn 368.99 Mn 34.39 Mn

Historic Data

Download Data
DateValue
Mar 31, 2026 -49.90%
Dec 31, 2025 -33.20%
Sep 30, 2025 -24.85%
Jun 30, 2025 -19.85%
Mar 31, 2025 -16.51%
Dec 31, 2024 -14.12%
Sep 30, 2024 -12.34%
Jun 30, 2024 -10.95%
Mar 31, 2024 0.37%
Dec 31, 2023 0.36%
Sep 30, 2023 0.35%
Jun 30, 2023 0.34%
Mar 31, 2023 0.32%
Dec 31, 2022 0.32%
Sep 30, 2022 0.32%
Jun 30, 2022 0.31%
Mar 31, 2022 0.30%
Dec 31, 2021 0.30%
Sep 30, 2021 -3.33%
Jun 30, 2021 0.94%